These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10845694)

  • 1. Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone.
    Lopez RF; Collett JH; Bentley MV
    Int J Pharm; 2000 Apr; 200(1):127-32. PubMed ID: 10845694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing effect of hydroxypropyl-beta-cyclodextrin on cutaneous penetration and activation of ethyl 4-biphenylyl acetate in hairless mouse skin.
    Arima H; Miyaji T; Irie T; Hirayama F; Uekama K
    Eur J Pharm Sci; 1998 Jan; 6(1):53-9. PubMed ID: 16256708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the influence of some cyclodextrins on the stratum corneum from the hairless mouse.
    Bentley MV; Vianna RF; Wilson S; Collett JH
    J Pharm Pharmacol; 1997 Apr; 49(4):397-402. PubMed ID: 9232537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
    Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K
    Pharm Dev Technol; 2000; 5(3):399-407. PubMed ID: 10934740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 2-hydroxypropyl-beta-cyclodextrin on percutaneous absorption of methyl paraben.
    Tanaka M; Iwata Y; Kouzuki Y; Taniguchi K; Matsuda H; Arima H; Tsuchiya S
    J Pharm Pharmacol; 1995 Nov; 47(11):897-900. PubMed ID: 8708982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of hydroxypropyl beta-cyclodextrin on the stability of benzylpenicillin in chloroacetate buffer.
    Ong JK; Sunderland VB; McDonald C
    J Pharm Pharmacol; 1997 Jun; 49(6):617-21. PubMed ID: 9330202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of hydroxypropyl-beta-cyclodextrin on the transdermal permeation and skin accumulation of oxybenzone.
    Felton LA; Wiley CJ; Godwin DA
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1117-24. PubMed ID: 12455470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible enhancing mechanism of the cutaneous permeation of 4-biphenylylacetic acid by beta-cyclodextrin derivatives in hydrophilic ointment.
    Arima H; Miyaji T; Irie T; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):582-6. PubMed ID: 8882455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the antiinflammatory effect of ethyl 4-biphenylyl acetate in ointment by beta-cyclodextrin derivatives: increased absorption and localized activation of the prodrug in rats.
    Arima H; Adachi H; Irie T; Uekama K; Pitha J
    Pharm Res; 1990 Nov; 7(11):1152-6. PubMed ID: 2293214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin.
    Ventura CA; Tommasini S; Falcone A; Giannone I; Paolino D; Sdrafkakis V; Mondello MR; Puglisi G
    Int J Pharm; 2006 May; 314(1):37-45. PubMed ID: 16581211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the percutaneous absorption-enhancing effects of cyclodextrin derivatives in rats.
    Vollmer U; Müller BW; Peeters J; Mesens J; Wilffert B; Peters T
    J Pharm Pharmacol; 1994 Jan; 46(1):19-22. PubMed ID: 8201522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic studies of the effect of hydroxypropyl-beta-cyclodextrin on in vitro transdermal permeation of corticosterone through hairless mouse skin.
    Shaker DS; Ghanem AH; Li SK; Warner KS; Hashem FM; Higuchi WI
    Int J Pharm; 2003 Mar; 253(1-2):1-11. PubMed ID: 12593932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized transdermal delivery of ketoprofen using pH and hydroxypropyl-beta-cyclodextrin as co-enhancers.
    Sridevi S; Diwan PV
    Eur J Pharm Biopharm; 2002 Sep; 54(2):151-4. PubMed ID: 12191685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal iontophoretic delivery of hydrocortisone from cyclodextrin solutions.
    Chang SL; Banga AK
    J Pharm Pharmacol; 1998 Jun; 50(6):635-40. PubMed ID: 9680073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of solubility and oral bioavailability of 2-(N-cyanoimino)-5-[(E)-4-styrylbenzylidene]-4-oxothiazolidine (FPFS-410) with antidiabetic and lipid-lowering activities in dogs by 2-hydroxypropyl-beta-cyclodextrin.
    Hara T; Hirayama F; Arima H; Yamaguchi Y; Uekama K
    Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):344-9. PubMed ID: 16508189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation into the mechanism by which cyclodextrins influence transdermal drug delivery.
    Kear CL; Yang J; Godwin DA; Felton LA
    Drug Dev Ind Pharm; 2008 Jul; 34(7):692-7. PubMed ID: 18608463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced nasal delivery of luteinizing hormone releasing hormone agonist buserelin by oleic acid solubilized and stabilized in hydroxypropyl-beta-cyclodextrin.
    Abe K; Irie T; Uekama K
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2232-7. PubMed ID: 8582025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipine.
    Yoshida A; Yamamoto M; Itoh T; Irie T; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):176-9. PubMed ID: 2337940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal lontophoresis and skin retention of piroxicam from gels containing piroxicam: hydroxypropyl-beta-cyclodextrin complexes.
    Doliwa A; Santoyo S; Ygartua P
    Drug Dev Ind Pharm; 2001 Sep; 27(8):751-8. PubMed ID: 11699826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced rectal absorption and reduced local irritation of the anti-inflammatory drug ethyl 4-biphenylylacetate in rats by complexation with water-soluble beta-cyclodextrin derivatives and formulation as oleaginous suppository.
    Arima H; Kondo T; Irie T; Uekama K
    J Pharm Sci; 1992 Nov; 81(11):1119-25. PubMed ID: 1447717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.